These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3523494)

  • 21. Lewis blood group and HLA matching in renal transplantation.
    Gratama JW; Hendriks GF; Persijn GG; de Lange P; van Nieuwkoop JA; Brand A
    Transplant Proc; 1987 Oct; 19(5):3651-2. PubMed ID: 3313880
    [No Abstract]   [Full Text] [Related]  

  • 22. HLA matching in transfused, cyclosporine-treated patients at Oxford.
    Ting A; Morris PJ
    Clin Transpl; 1987; ():235-8. PubMed ID: 3154408
    [No Abstract]   [Full Text] [Related]  

  • 23. Transfusion pretreatment of renal transplant patients.
    Opelz G
    Prog Clin Biol Res; 1986; 224():195-208. PubMed ID: 3540992
    [No Abstract]   [Full Text] [Related]  

  • 24. Cyclosporine-steroids versus conventional therapy in cadaver kidney transplantation: analysis of a randomized trial at two years.
    Gianello P; Squifflet JP; Pirson Y; Stoffel M; Dereme T; Alexandre GP
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1867-72. PubMed ID: 3547891
    [No Abstract]   [Full Text] [Related]  

  • 25. Histocompatibility testing in clinical renal transplantation.
    Braun WE
    Urol Clin North Am; 1983 May; 10(2):231-42. PubMed ID: 6222529
    [No Abstract]   [Full Text] [Related]  

  • 26. Pretransplant immunologic considerations.
    Thorsby E; Ettenger R; Garovoy M
    Transplant Proc; 1984 Dec; 16(6):1649-53. PubMed ID: 6390879
    [No Abstract]   [Full Text] [Related]  

  • 27. Method of preservation is not a determinant of graft outcome in kidneys transplanted by Southeastern Organ Procurement Foundation Institutions.
    Vaughn WK; Mendez-Picon G; Humphries AL; Spees EK
    Transplantation; 1981 Dec; 32(6):490-4. PubMed ID: 7041350
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The importance of tissue typing in cadaveric kidney transplantation (discussion).
    Contrib Nephrol; 1982; (34):122-7. PubMed ID: 6756778
    [No Abstract]   [Full Text] [Related]  

  • 29. Kidney graft survival: role of blood transfusions and lymphocytotoxic antibodies.
    Fradet Y; Roy R; Lachance JG; Noël R
    Clin Nephrol; 1982 Aug; 18(2):69-73. PubMed ID: 6754190
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quadruple drug therapy prevents graft loss from acute rejection without increasing mortality.
    Light JA; Aquino A; Ali A; Rodriguez R; Ali S
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1927-30. PubMed ID: 3547897
    [No Abstract]   [Full Text] [Related]  

  • 31. A multi-factor analysis of kidney graft outcomes at one and five years posttransplantation: 1996 UNOS Update.
    Gjertson DW
    Clin Transpl; 1996; ():343-60. PubMed ID: 9286581
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The relationship of transfusion and presensitization with graft and patient survival.
    Sanfilippo F; Vaughn WK; Bollinger RR; Spees EK
    Transplant Proc; 1982 Jun; 14(2):287-9. PubMed ID: 7051467
    [No Abstract]   [Full Text] [Related]  

  • 33. Significance of delayed function in cyclosporine-treated cadaver kidney transplants.
    Belitsky P; MacDonald AS; Gajewski J; Boudreau J; Bitter-Suermann H; Cohen A
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2096-9. PubMed ID: 3547912
    [No Abstract]   [Full Text] [Related]  

  • 34. Blood transfusions before and on the day of transplantation: effects on cadaver graft survival.
    Feduska NJ; Amend WJ; Vincenti F; Duca R; Salvatierra O
    Transplant Proc; 1982 Jun; 14(2):302-4. PubMed ID: 7051470
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Possible mechanism of the beneficial effect of pretransplant blood transfusions on renal allograft survival in man.
    Singal DP; Joseph S; Szewczuk MR
    Transplant Proc; 1982 Jun; 14(2):316-8. PubMed ID: 6214059
    [No Abstract]   [Full Text] [Related]  

  • 36. Effects of allostimulation and cyclosporine therapy on cytotoxic antibody production in highly sensitized prospective renal transplant recipients.
    Weir MR; Shen SY; Dagher FJ; Bentley FR; Lesko LJ; Sadler JH
    Transplantation; 1988 Oct; 46(4):591-4. PubMed ID: 3051568
    [No Abstract]   [Full Text] [Related]  

  • 37. Multifactorial analysis of factors influencing graft survival in recipients of living related renal allografts.
    Green WF; Niblack GD; Johnson HK; Richie RE; Tallent MB; MacDonnell R; Turner B; Harbison P; Ganaway S
    Transplant Proc; 1982 Jun; 14(2):282-6. PubMed ID: 6214057
    [No Abstract]   [Full Text] [Related]  

  • 38. There is no need to give blood transfusions as pretreatment for renal transplantation in the cyclosporine era.
    Groth CG
    Transplant Proc; 1987 Feb; 19(1 Pt 1):153-4. PubMed ID: 3079151
    [No Abstract]   [Full Text] [Related]  

  • 39. Cadaver donor renal transplantation by centers of the South-Eastern Organ Procurement Foundation. The prospective study after 6.5 years and 3811 allografts.
    McDonald JC; Vaughn W; Filo RS; Mendez-Picon G; Niblack G; Spees EK; Williams GM
    Ann Surg; 1984 Oct; 200(4):535-42. PubMed ID: 6385877
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Blood transfusion in renal transplantation.
    Persijn GG
    Ann Clin Res; 1981; 13(4-5):215-23. PubMed ID: 7039481
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.